Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000186611 | SCV000167713 | benign | not specified | 2013-09-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000724570 | SCV000230960 | uncertain significance | not provided | 2015-02-09 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000186611 | SCV000612735 | benign | not specified | 2017-07-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080268 | SCV000658065 | benign | Autosomal dominant nocturnal frontal lobe epilepsy | 2024-12-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316348 | SCV000851347 | likely benign | Inborn genetic diseases | 2016-11-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003952645 | SCV004772389 | likely benign | CHRNA4-related disorder | 2019-04-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |